A detailed history of J.W. Cole Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 15,774 shares of AMGN stock, worth $4.71 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
15,774
Previous 14,313 10.21%
Holding current value
$4.71 Million
Previous $4.47 Million 13.64%
% of portfolio
0.22%
Previous 0.21%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$309.38 - $337.38 $452,004 - $492,912
1,461 Added 10.21%
15,774 $5.08 Million
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $1.23 Million - $1.5 Million
4,697 Added 48.85%
14,313 $4.47 Million
Q1 2024

Apr 30, 2024

BUY
$268.87 - $324.56 $50,547 - $61,017
188 Added 1.99%
9,616 $2.73 Million
Q4 2023

Jan 31, 2024

BUY
$255.7 - $288.46 $1.7 Million - $1.92 Million
6,643 Added 238.53%
9,428 $2.72 Million
Q3 2023

Oct 24, 2023

BUY
$218.65 - $271.46 $63,845 - $79,266
292 Added 11.71%
2,785 $748,000
Q2 2023

Jul 27, 2023

SELL
$214.27 - $253.37 $192,414 - $227,526
-898 Reduced 26.48%
2,493 $553,000
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $4,290 - $5,228
19 Added 0.56%
3,391 $819,000
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $40,309 - $51,217
-176 Reduced 4.96%
3,372 $885,000
Q3 2022

Oct 31, 2022

BUY
$224.46 - $253.15 $86,866 - $97,969
387 Added 12.24%
3,548 $800,000
Q2 2022

Jul 27, 2022

SELL
$230.71 - $256.74 $113,278 - $126,059
-491 Reduced 13.44%
3,161 $769,000
Q1 2022

Jun 10, 2022

SELL
$219.27 - $242.57 $192 Million - $212 Million
-875,150 Reduced 99.58%
3,652 $883,000
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $192 Million - $212 Million
875,052 Added 23334.72%
878,802 $349,000
Q4 2021

Jan 25, 2022

SELL
$198.88 - $227.6 $39,179 - $44,837
-197 Reduced 4.99%
3,750 $844,000
Q3 2021

Oct 26, 2021

BUY
$212.27 - $248.7 $37,784 - $44,268
178 Added 4.72%
3,947 $839,000
Q2 2021

Aug 06, 2021

BUY
$233.58 - $259.14 $57,227 - $63,489
245 Added 6.95%
3,769 $919,000
Q1 2021

Apr 28, 2021

SELL
$221.91 - $258.6 $84,103 - $98,009
-379 Reduced 9.71%
3,524 $877,000
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $1.35 Million - $1.61 Million
-6,254 Reduced 61.57%
3,903 $897,000
Q3 2020

Nov 05, 2020

BUY
$234.65 - $260.95 $2.38 Million - $2.65 Million
10,157 New
10,157 $2.58 Million
Q1 2020

May 07, 2020

SELL
$182.24 - $241.7 $963,867 - $1.28 Million
-5,289 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$189.21 - $243.2 $1 Million - $1.29 Million
5,289 New
5,289 $1.28 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $160B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.